ARCHIVES

Committee Unblinds Phase III Zytiga Study

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

Project Expands Group Studies To Community Oncologists.

March 10, 2000

SEER Program Expansion Through Cost-Sharing.

March 23, 2001

Komen Foundation Announces Second Grant Cycle For 1995

April 28, 1995

Screening Guidelines Differ Among Major Medical Organizations

January 16, 1998

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014